Jefferies Reiterates Buy Rating on Avon Products (AVP)

Jefferies & Co. is out with an analyst note this morning, where they reiterate their Buy rating on shares of Avon Products AVP; they have a $43.00 price target on the stock. Jefferies said, “We believe the recent currency devaluation in Venezuela will be about a -$0.07 per share drag to 2010E EPS vs. 2009E, +/- $0.01-$0.02 depending on how long it takes to recapture pricing; currently mgt is lagging on pricing in an effort to increase share during this period of dislocation. We also note that the closing of the parallel exchange market is essentially a non-event for AVP, so we view the situation in Venezuela as largely known and contained, barring further official devaluations. Only 7% of AVP's cash is in the country, and it is comfortably able to finance non-Bolivar sourcing temporarily via other AVP subsidiaries if necessary.” Meanwhile, organic growth rates have been in the upper single digits, and margins should benefit from having a larger portion of its cost saving initiatives fall to the bottom line now that investments in advertising and the Representative Value Proposition (RVP) have nearly reached scale. Jefferies noted, “Assuming a 20% incremental operating margin on our +9% organic sales growth forecast, we look for 2010E organic EPS growth in the mid-teens, contributing +$0.29 p/s. In addition, if the company delivers on its cumulative target of $875 mil in savings and benefits from its restructuring and alphabet soup initiatives in 2010E on top of the $635 mil in 2009, that's an additional +$0.36 p/s benefit to 2010E ongoing EPS.”
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsConsumer StaplesHealth CareHealth Care SuppliesJefferies & CoPersonal Products
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!